Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2001 | 03-2000 | 03-1999 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 7,603 | 4,500 | 1,550 |
| Receivables | 13 | 0 | 0 |
| Other current assets | 81 | 340 | 60 |
| TOTAL | $7,779 | $4,840 | $1,610 |
| Non-Current Assets | |||
| PPE Net | 3,891 | 2,470 | 1,250 |
| Intangibles | 57 | 0 | 0 |
| Other Non-Current Assets | 623 | 1,820 | 200 |
| TOTAL | $4,572 | $4,290 | $1,450 |
| Total Assets | $12,350 | $9,160 | $3,070 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 120 | 110 | 0 |
| Accounts payable and accrued liabilities | 220 | 590 | 100 |
| Accrued Expenses | N/A | 0 | 100 |
| Other current liabilities | 65 | 0 | 0 |
| TOTAL | $405 | $710 | $240 |
| Non-Current Liabilities | |||
| Long Term Debt | 2,765 | 2,880 | 0 |
| TOTAL | $2,765 | $2,880 | $N/A |
| Total Liabilities | $3,170 | $3,590 | $240 |
| Shareholders' Equity | |||
| Common Shares | 94 | 80 | 70 |
| Retained earnings | -21,000 | -7,030 | -4,050 |
| Other shareholders' equity | 12,015 | 0 | -10 |
| TOTAL | $9,180 | $5,560 | $2,820 |
| Total Liabilities And Equity | $12,350 | $9,150 | $3,060 |